Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
Wednesday, March 18, 2026Liminatus today announced plans to initiate a Phase clinical trial evaluating IBA a nextgeneration CDblocking monoclonal antibody designed to engage innate immune pathways and complement established immunooncology therapies
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
Wednesday, March 18, 2026Polaryx Therapeutics Inc a clinicalstage biotechnology company developing diseasemodifying therapies for rare pediatric lysosomal storage disorders LSDs today announced that the US Food and Drug Administration
Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide
Tuesday, March 17, 2026Samsung Bioepis Co Ltd and Epis NexLab Co Ltd a sister company to Samsung Bioepis under Samsung Epis Holdings KRX Z today announced a research collaboration and license agreement with GGBIO
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
Tuesday, March 17, 2026Piramal Pharma Solutions a leading global Contract Development and Manufacturing Organization CDMO and part of Piramal Pharma Ltd NSE PPLPHARMA BSE is proud to announce the completion
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
Friday, March 13, 2026GenScript announced the official opening of its first European mRNA production site in Delft the Netherlands marking a significant expansion of the companys global mRNA platform and reinforcing Europe as a core pillar
George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea
Thursday, March 12, 2026George Medicines a latestage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease has entered into an exclusive licensing and supply agreement with Ahngook
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
Wednesday, March 11, 2026SciSparc Ltd today announced that NeuroThera Labs Inc TSXV NTLX NeuroThera a clinicalstage pharmaceutical company focused on developing novel treatments for central nervous system disorders
The 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard
Tuesday, March 10, 2026When we discuss bacterial infections we often think of exotoxinsthose soluble proteins actively secreted by bacteriawhile overlooking endotoxins which are more insidious but equally dangerous Endotoxins are not released by bacteria rather they are na...
Upperton Submits MHRA Licence Application for Annex 1 Sterile Manufacturing Facility Following APS Validation
Saturday, March 07, 2026Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency MHRA for the approval of its new sq ft sterile manufacturing facility The submission follows the successful execution
Frontage Laboratories Completes Acquisition of Teddy Lab, Strengthening Global Central Laboratory Capabilities
Thursday, March 05, 2026Frontage Laboratories Inc Frontage a leading global CROCDMO today announced the completion of the acquisition of Teddy Clinical Research Laboratory Shanghai Ltd Teddy Lab a leading clinical research
